ADIAL PHARMACEUTICALS INC (ADIL)
NASDAQHealth CareBiotechnologySnapshot 2026-09-04
$7.12+6.91%
Close 2026-09-04 · 1-day change
NASDAQHealth CareBiotechnologySnapshot 2026-09-04
QuarterlyIQ Insights · ADIL
Income statement, balance sheet, and cash flow — annual and quarterly history, as reported.
Figures in millions of None, except per-share and ratios.
| TTM | Dec 2025 | Dec 2024 | Dec 2023 | Dec 2022 | Dec 2021 | Dec 2020 | Dec 2019 | Dec 2018 | |
|---|---|---|---|---|---|---|---|---|---|
| Operating Expenses & Income | |||||||||
| R&D Expenses | 2.0 | 2.6 | 3.2 | 1.3 | 2.0 | 8.4 | 5.9 | 4.0 | 0.4 |
| Operating Income | (57.7) | (7.8) | (8.3) | (6.9) | (10.9) | (19.3) | (10.9) | (8.2) | (7.0) |
| Earnings from Continuing Operations | |||||||||
| Interest & Investment Income | 0.2 | 0.1 | 0.2 | 0.1 | 0.1 | 0.0 | 0.0 | 0.1 | 0.0 |
| Other Non-Operating Income / Expenses | (0.1) | (0.2) | (4.9) | (0.1) | 0.1 | (0.2) | 0.0 | (0.3) | (4.6) |
| Asset Writedown | — | — | — | — | — | 1.5 | — | — | — |
| EBT, Incl. Unusual Items | — | (8.0) | (13.2) | (7.0) | (10.8) | (19.5) | (10.9) | (8.6) | (11.6) |
| Income Tax Expense | — | — | — | — | (0.0) | (0.1) | — | — | — |
| Earnings from Continuing Operations | — | — | — | (7.0) | (10.8) | — | — | — | — |
| Net Income | |||||||||
| Net Income | (7,978,049.8) | (8.0) | (13.2) | (5.1) | (12.7) | (19.4) | (10.9) | (8.6) | (11.6) |
| Per Share | |||||||||
| Basic EPS | (1,726,202.35) | (11.93) | (2.72) | (3.60) | (12.71) | (1.04) | — | — | — |
| Diluted EPS | (1,726,202.35) | (11.93) | (2.72) | (3.60) | (12.71) | (1.04) | — | — | — |
| Basic Weighted Avg Shares | 4.6 | 0.7 | — | — | 25.0 | 18.6 | — | — | — |
| Diluted Weighted Avg Shares | 4.6 | 0.7 | 4.9 | 1.4 | 1.0 | 18.6 | — | — | 0.2 |
| Supplemental | |||||||||
| EBIT | (57.7) | (7.8) | (8.3) | (6.9) | (10.9) | (19.3) | (10.9) | (8.2) | (7.0) |
| Effective Tax Rate | — | — | — | — | 0.0% | 0.5% | — | — | — |
Not investment advice. Scores describe historical and current data; they are not forecasts of future returns. Consult a licensed advisor before making investment decisions.